<DOC>
	<DOCNO>NCT00000735</DOCNO>
	<brief_summary>To determine safety intravenous infusion ampligen symptomatic HIV-infected patient several dose level , determine maximum dose tolerate , measure effect ampligen HIV virus infection , immune function , clinical condition . Ampligen suitable drug clinical trial HIV show stimulate immune system inhibit replication HIV vitro dose achieve without noticeable harmful side effect .</brief_summary>
	<brief_title>A Clinical Trial To Evaluate Toxicity Antiviral Effects Range Doses Ampligen p24 Antigen Positive HIV-Infected Patients With AIDS ARC</brief_title>
	<detailed_description>Ampligen suitable drug clinical trial HIV show stimulate immune system inhibit replication HIV vitro dose achieve without noticeable harmful side effect . Patients enter study give ampligen intravenous infusion hemophilia treatment center first week trial twice week follow 12 week . The dose patient receives determine response earlier patient . If status HIV infection improve first 13 week , ampligen stop . Each patient maintain daily diary listing symptom problem occur headache , nausea , change appetite . Other anti-HIV drug take trial , aspirin acetaminophen take 72 hour time trial without consult research staff . Blood drawn interval 13-week trial 8-week follow-up use determine effect ampligen HIV immune system well monitor toxicity side effect .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>HIV Seropositivity</mesh_term>
	<mesh_term>Antiviral Agents</mesh_term>
	<mesh_term>poly ( I ) .poly ( c12 , U )</mesh_term>
	<mesh_term>Poly I-C</mesh_term>
	<criteria>Inclusion Criteria Hemophiliacs include . Patients must : Consistently positive serum HIV p24 antigen ( = &gt; 70 pg/ml ) define Abbott HIV antigen test . This demonstration must see two occasion , separate least 72 hour , last must within 2 week start therapy . Positive HIV antibody test . Prior Medication : Allowed : Acyclovir short course ( 7 day ) . Ketoconazole short course ( 7 day ) . Aerosolized pentamidine Pneumocystis carinii pneumonia ( PCP ) prophylaxis . Trimethoprim / sulfamethoxazole PCP prophylaxis . Exclusion Criteria Coexisting Condition : Patients AIDS encephalopathy sole indicator exclude . Patients AIDS encephalopathy sole indicator exclude . Prior Medication : Excluded : Other experimental medication . Antineoplastic therapy . Amphotericin B. Ganciclovir . Excluded within 14 day study entry : Biologic modifier . Corticosteroids . Excluded within 30 day study entry : Other antiretroviral agent . Excluded within 60 day study entry : Ribavirin . Active drug alcohol abuse .</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Virus Replication</keyword>
	<keyword>T-Lymphocytes</keyword>
	<keyword>Infusions , Intravenous</keyword>
	<keyword>Immunologic Surveillance</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>ampligen</keyword>
	<keyword>AIDS-Related Complex</keyword>
	<keyword>Antiviral Agents</keyword>
</DOC>